Active Ingredient History

  • Now
Aflibercept, sold under the brand names Eylea and Zaltrap, is a medication used to treat wet macular degeneration and metastatic colorectal cancer. It was developed by Regeneron Pharmaceuticals and is approved in the United States and the European Union.   Wikipedia

More Chemistry

Drug Pricing (per unit)

United States

$611.5300 - $1840.7000


More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

afilbercept | aflibercept | alfilbercept | ave0005 | ave 0005 | ave-0005 | ave005 | ave 005 | ave-005 | eylea | vascular endothelial growth factor trap-eye | vegf trap | vegf-trap | vegf trap-eye | vegf trap - regeneron | zaltrap | ziv-aflibercept


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue